{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:43:51Z","timestamp":1790376231968,"version":"4.1.0"},"reference-count":31,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Psychopharmacol Clin Exp"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1002\/hup.2593","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T10:52:56Z","timestamp":1495104776000},"page":"e2593","source":"Crossref","is-referenced-by-count":14,"title":["The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study"],"prefix":"10.1002","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0526-3136","authenticated-orcid":false,"given":"Baptiste","family":"Pignon","sequence":"first","affiliation":[{"name":"Psychiatry and Addiction Medicine Department; CHU Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Labreuche","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Univ. Lille, CHU Lille, EA 2694 - Sant\u00e9 publique : \u00e9pid\u00e9miologie et qualit\u00e9 des soins; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Auffret","sequence":"additional","affiliation":[{"name":"INSERM U1171; pharmacovigilance - addictovigilance, Univ. Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Gautier","sequence":"additional","affiliation":[{"name":"INSERM U1171; pharmacovigilance - addictovigilance, Univ. Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Deheul","sequence":"additional","affiliation":[{"name":"INSERM U1171; pharmacovigilance - addictovigilance, Univ. Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Simioni","sequence":"additional","affiliation":[{"name":"Psychiatry and Addiction Medicine Department; CHU Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cottencin","sequence":"additional","affiliation":[{"name":"Psychiatry and Addiction Medicine Department; CHU Lille; Lille France"},{"name":"CNRS, UMR 9193, SCALab - PsyCHIC Team; Univ. Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Bordet","sequence":"additional","affiliation":[{"name":"INSERM U1171; pharmacovigilance - addictovigilance, Univ. Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Duhamel","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; Univ. Lille, CHU Lille, EA 2694 - Sant\u00e9 publique : \u00e9pid\u00e9miologie et qualit\u00e9 des soins; Lille France"},{"name":"CERIM; Univ. Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rolland","sequence":"additional","affiliation":[{"name":"Psychiatry and Addiction Medicine Department; CHU Lille; Lille France"},{"name":"INSERM U1171; pharmacovigilance - addictovigilance, Univ. Lille; Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,18]]},"reference":[{"issue":"5","key":"10.1002\/hup.2593-BIB0001|hup2593-cit-0002","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/alcalc\/37.5.504","article-title":"Baclofen efficacy in reducing alcohol craving and Intake: A preliminary double-blind randomized controlled study","volume":"37","author":"Addolorato","year":"2002","journal-title":"Alcohol and Alcoholism"},{"issue":"3","key":"10.1002\/hup.2593-BIB0002|hup2593-cit-0003","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/alcalc\/agr017","article-title":"Dose-response effect of baclofen in reducing daily alcohol Intake in alcohol dependence: Secondary analysis of a randomized, double-blind, placebo-controlled trial","volume":"46","author":"Addolorato","year":"2011","journal-title":"Alcohol and Alcoholism"},{"issue":"9603","key":"10.1002\/hup.2593-BIB0003|hup2593-cit-0004","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: Randomised, double-blind controlled study","volume":"370","author":"Addolorato","year":"2007","journal-title":"The Lancet"},{"key":"10.1002\/hup.2593-BIB0004|hup2593-cit-0005","unstructured":"Agence Fran\u00e7aise du M\u00e9dicament et des produits de sant\u00e9 2014 [Recommandation temporaire d'utilisation (RTU) pour le baclof\u00e8ne - Point d'information] temporary recommendation for use (TRU) for baclofen http:\/\/ansm.sante.fr\/S-informer\/Points-d-information-Points-d-information\/Une-recommandation-temporaire-d-utilisation-RTU-est-accordee-pour-le-baclofene-Point-d-information"},{"issue":"2","key":"10.1002\/hup.2593-BIB0006|hup2593-cit-0007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/alcalc\/agh130","article-title":"Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: A self-case report of a physician","volume":"40","author":"Ameisen","year":"2005","journal-title":"Alcohol and Alcoholism"},{"key":"10.1002\/hup.2593-BIB0007|hup2593-cit-0008","unstructured":"BACLOVILLE study (NCT01604330) 2015 Baclofen for the treatment of alcohol drinkers-Full text view-ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01604330?term=baclofen+alcohol&rank=9"},{"issue":"12","key":"10.1002\/hup.2593-BIB0008|hup2593-cit-0009","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.euroneuro.2016.10.006","article-title":"Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial","volume":"26","author":"Beraha","year":"2016","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/hup.2593-BIB0009|hup2593-cit-0010","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/0269881111408463","article-title":"Substitution therapy for alcoholism: Time for a reappraisal?","volume":"26","author":"Chick","year":"2012","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"key":"10.1002\/hup.2593-BIB0010|hup2593-cit-0011","unstructured":"French Alcohol Society [Soci\u00e9t\u00e9 Fran\u00e7aise d'Alcoologie] 2015 Alcohol misuse: Screening, diagnosis and treatment http:\/\/www.sfalcoologie.asso.fr"},{"issue":"11","key":"10.1002\/hup.2593-BIB0011|hup2593-cit-0012","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1530-0277.2010.01273.x","article-title":"Efficacy and safety of baclofen for alcohol dependence: A randomized, double-blind, placebo-controlled trial","volume":"34","author":"Garbutt","year":"2010","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"11","key":"10.1002\/hup.2593-BIB0012|hup2593-cit-0013","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.euroneuro.2013.02.006","article-title":"A randomised, double-blind, placebo-controlled, efficacy study of nalmefene, as-needed use, in patients with alcohol dependence","volume":"23","author":"Gual","year":"2013","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/hup.2593-BIB0013|hup2593-cit-0014","volume-title":"The placebo effect: An interdisciplinary exploration","author":"Harrington","year":"1999"},{"issue":"4","key":"10.1002\/hup.2593-BIB0014|hup2593-cit-0015","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1111\/j.1530-0277.1998.tb03892.x","article-title":"Prevalence of alcohol dependence and abuse in general practice","volume":"22","author":"Hill","year":"1998","journal-title":"Alcoholism: Clinical and Experimental Research"},{"issue":"9","key":"10.1002\/hup.2593-BIB0015|hup2593-cit-0016","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1111\/acer.12823","article-title":"Anticraving effect of baclofen in alcohol-dependent patients","volume":"39","author":"Imbert","year":"2015","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"10.1002\/hup.2593-BIB0016|hup2593-cit-0017","volume-title":"Cinical efficacy study of high dose baclofen in reducing alcohol consumption (oral communication)","author":"Jaury","year":"2016"},{"issue":"8","key":"10.1002\/hup.2593-BIB0017|hup2593-cit-0018","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.biopsych.2012.10.020","article-title":"Extending the treatment options in alcohol dependence: A randomized controlled study of as-needed nalmefene","volume":"73","author":"Mann","year":"2013","journal-title":"Biological Psychiatry"},{"issue":"23","key":"10.1002\/hup.2593-BIB0018|hup2593-cit-0019","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.2174\/1381612821666150619091858","article-title":"GABAB agonists for the treatment of alcohol use disorder","volume":"21","author":"Mirijello","year":"2015","journal-title":"Current Pharmaceutical Design"},{"issue":"8","key":"10.1002\/hup.2593-BIB0019|hup2593-cit-0020","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.euroneuro.2015.04.002","article-title":"High-dose baclofen for the treatment of alcohol dependence (BACLAD study): A randomized, placebo-controlled trial","volume":"25","author":"M\u00fcller","year":"2015","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/hup.2593-BIB0020|hup2593-cit-0021","volume-title":"A randomized, double blind, placebo-controlled efficacy study of high-dose baclofen in alcohol dependent patients: The \u2018ALPADIR\u2019 study (oral communication)","author":"Reynaud","year":"2016"},{"issue":"4","key":"10.1002\/hup.2593-BIB0021|hup2593-cit-0022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1360-0443.2011.03752.x","article-title":"Alcohol-dependence: The current French craze for baclofen","volume":"107","author":"Rolland","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1002\/hup.2593-BIB0022|hup2593-cit-0023","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/JCP.0b013e3182860e84","article-title":"Baclofen for alcohol-dependence: Anticraving or partial substitution?","volume":"33","author":"Rolland","year":"2013","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1002\/hup.2593-BIB0023|hup2593-cit-0024","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2515\/therapie\/2010073","article-title":"[Un dispositif de prescriptions hors-AMM: Exemple du baclof\u00e8ne] A system of prescriptions without drug approval: Example of baclofen","volume":"65","author":"Rolland","year":"2010","journal-title":"Th\u00e9rapie"},{"issue":"10","key":"10.1002\/hup.2593-BIB0024|hup2593-cit-0025","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.euroneuro.2015.05.008","article-title":"Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation","volume":"25","author":"Rolland","year":"2015b","journal-title":"European Neuropsychopharmacology: The Journal of the European College of Neuropsychopharmacology"},{"issue":"6","key":"10.1002\/hup.2593-BIB0025|hup2593-cit-0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098062","article-title":"Off-label baclofen prescribing practices among French alcohol specialists: Results of a national online survey","volume":"9","author":"Rolland","year":"2014","journal-title":"PloS One"},{"issue":"1","key":"10.1002\/hup.2593-BIB0026|hup2593-cit-0027","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/cns.12489","article-title":"Pharmacotherapy for alcohol dependence: The 2015 recommendations of the French alcohol society, issued in partnership with the European Federation of Addiction Societies","volume":"22","author":"Rolland","year":"2016","journal-title":"CNS Neuroscience & Therapeutics"},{"issue":"1","key":"10.1002\/hup.2593-BIB0027|hup2593-cit-0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/YIC.0000000000000054","article-title":"Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: A comparative cohort study","volume":"30","author":"Rolland","year":"2015a","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/hup.2593-BIB0028|hup2593-cit-0029","unstructured":"SAS Institute, Cary, NC 2011 SAS 9.3 software overview http:\/\/support.sas.com\/software\/93\/"},{"issue":"4","key":"10.1002\/hup.2593-BIB0029|hup2593-cit-0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1360-0443.1988.tb00485.x","article-title":"Reliability of a timeline method: Assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations","volume":"83","author":"Sobell","year":"1988","journal-title":"British Journal of Addiction"},{"key":"10.1002\/hup.2593-BIB0030|hup2593-cit-0031","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.pbb.2013.10.009","article-title":"The neurobiology of alcohol consumption and alcoholism: An integrative history","volume":"113","author":"Tabakoff","year":"2013","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"8","key":"10.1002\/hup.2593-BIB0031|hup2593-cit-0032","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/0269881114527362","article-title":"Long-term efficacy, tolerability and safety of nalmefene as-needed in patients with alcohol dependence: A 1-year, randomised controlled study","volume":"28","author":"Brink","year":"2014","journal-title":"Journal of Psychopharmacology (Oxford, England)"},{"issue":"9596","key":"10.1002\/hup.2593-BIB0032|hup2593-cit-0033","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"Elm","year":"2007","journal-title":"Lancet (London, England)"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.2593","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/hup.2593\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:02:34Z","timestamp":1625162554000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.2593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,18]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"URL":"https:\/\/doi.org\/10.1002\/hup.2593","archive":["Portico"],"relation":{},"ISSN":["0885-6222"],"issn-type":[{"value":"0885-6222","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5,18]]}}}